MURA Stock Price | Mural Oncology plc P/E, Revenue, EPS, & Forecasts

Mural Oncology plc • MURA

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About Mural Oncology plc

Ticker

MURA

Trading on

NASDAQ

ISIN

IE000LK2BOB4

Industry

Biotechnology

Sector

Healthcare

CEO

Caroline J. Loew Ph.D.

Headquarters

10 Earlsfort Terrace, Dublin, undefined, Ireland, D02 T380

Employees

116

Website

muraloncology.com

Mural Oncology plc operates as a clinical-stage oncology company that focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops nemvaleukin to treat cutaneous melanoma and advanced solid tumors. The company also develops engineered interleukin-18 and tumor-targeted interleukin-12 programs. Mural Oncology plc was incorporated in 2017 and is based in Dublin, Ireland.

Metrics

BasicAdvanced

Market cap

$36M

P/E ratio

EPS

-$8.58

Dividend Yield

0.00%

Beta

Forward P/E ratio

EBIDTA

$-132M

Ex dividend date

Price & volume

Market cap

$36M

Average daily volume

0.1M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

Price to book

0.61

Earnings

EPS

-$8.58

EPS estimate (current quarter)

-$1.00

EPS estimate (next quarter)

-$0.30

EBITDA

$-132M

Revenues (TTM)

$0M

Revenues per share (TTM)

$0.00

Technicals

Beta

52-week High

$4.74

52-week Low

$0.95

50-day moving average

$2.08

200-day moving average

$2.57

Short ratio

3.11

Short %

2.75%

Management effectiveness

ROE (TTM)

-111.75%

ROA (TTM)

-52.60%

Profit margin

0.00%

Gross profit margin

$0M

Operating margin

0.00%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

0.00%

Share stats

Outstanding Shares

17.3M

Float

12.1M

Insiders %

13.49%

Institutions %

58.28%

Analyst Insights & forecasts

50% Buy

50% Hold

0% Sell

Based on information from 4 analysts.

Average price target

$6.00

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$1.87

-$1.97

5.08%

Q3 • 24Beat

-$2.01

-$1.99

-1.01%

Q4 • 24Missed

-$1.93

-$1.98

2.53%

Q1 • 25Beat

-$2.78

-$1.10

-152.73%

Q2 • 25Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$0M

$-33.1M

-∞%

Q1 • 25

$0M

$-48M

-∞%

Q2 • 25

NaN%

44.80%

NaN%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$132M

$24.2M

18.32%

Q1 • 25

$87.6M

$28.8M

32.86%

Q2 • 25

-33.71%

18.93%

79.41%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-36.8M

$28M

$0M

$-36.8M

Q1 • 25

$-31.4M

$1.8M

$0M

$-31.4M

Q2 • 25

-14.77%

-93.66%

-100.00%

-14.78%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Mural Oncology plc share?

Mural Oncology plc shares are currently traded for undefined per share.

How many shares does Mural Oncology plc have?

Mural Oncology plc currently has 17.3M shares.

Does Mural Oncology plc pay dividends?

No, Mural Oncology plc doesn't pay dividends.

What is Mural Oncology plc 52 week high?

Mural Oncology plc 52 week high is $4.74.

What is Mural Oncology plc 52 week low?

Mural Oncology plc 52 week low is $0.95.

What is the 200-day moving average of Mural Oncology plc?

Mural Oncology plc 200-day moving average is $2.57.

Who is Mural Oncology plc CEO?

The CEO of Mural Oncology plc is Caroline J. Loew Ph.D..

How many employees Mural Oncology plc has?

Mural Oncology plc has 116 employees.

What is the market cap of Mural Oncology plc?

The market cap of Mural Oncology plc is $36M.

What is the P/E of Mural Oncology plc?

The current P/E of Mural Oncology plc is null.

What is the EPS of Mural Oncology plc?

The EPS of Mural Oncology plc is -$8.58.

What is the PEG Ratio of Mural Oncology plc?

The PEG Ratio of Mural Oncology plc is null.

What do analysts say about Mural Oncology plc?

According to the analysts Mural Oncology plc is considered a buy.